This process permits the development of endless quantities of a selected antibody by fusing an antibody-making cell that has a myeloma cell. This fusion yields hybrid cells, or hybridomas, that may be cultured to create a gentle supply of the desired monoclonal antibodies.It means buying countrywide responses to prevent the slide from fragile to un